National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Clinical Trials (PDQ®)
Patient VersionHealth Professional Version
Last Modified: 5/22/2007     First Published: 4/20/2007  
Page Options
Print This Page  Print This Page
E-Mail This Document  E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Radiation Plus Hormone Therapy for Prostate Cancer

5-FU-Based Chemo Cures Some Colon Cancers

Past Highlights
Study of Psychological and Sociological Factors Predisposing the Development of Chronic Pain After Surgery in Women With Resectable Breast Cancer

Alternate Title
Basic Trial Information
Objectives
Entry Criteria
Expected Enrollment
Outcomes
Outline
Trial Contact Information
Registry Information

Alternate Title

Psychological and Social Factors That May Increase the Risk of Developing Chronic Pain After Surgery in Women With Breast Cancer

Basic Trial Information

Phase
Type
Status
Age
Sponsor
Protocol IDs

No phase specified


Natural history/Epidemiology


Closed


Over 18


Other


IB-2005-31
INCA-RECF0143, IB-SDPM, IB2005-31, NCT00466830

Objectives

Primary

  1. Determine the psychological and sociological factors that predispose post-mastectomy pain syndrome after surgery in women with resectable breast cancer.

Secondary

  1. Determine the psychological and sociological factors that predispose post-surgical pain in these patients.
  2. Evaluate emotional distress over time in these patients.
  3. Evaluate the acute and chronic pain over time in these patients.

Entry Criteria

Disease Characteristics:

  • Diagnosis of breast cancer


  • Mastectomy or lumpectomy, including axillary lymph node dissection, planned


  • Analgesic fixed (or ordered) the morning of surgery
    • No stage III analgesic planned


  • Hormone receptor status not specified


Prior/Concurrent Therapy:

  • No recent major surgery
  • No participation in another medical or surgical clinical trial in the past 30 days
  • Prior breast surgery for a benign lesion or malignant lesion allowed

Patient Characteristics:

  • Female
  • Menopausal status not specified
  • WHO performance status 0-2
  • Other prior malignancy allowed
  • No American Society of Anesthesiologists' class IV
  • No contraindication or drug addiction
  • No uncontrolled conditions, including any of the following:
    • Diabetes
    • Thyroid disease
    • Neuropsychiatric disease
    • Infection
    • Insufficient coronary function
    • NYHA class III-IV heart disease

Expected Enrollment

150

A total of 150 patients will be accrued for this study.

Outcomes

Primary Outcome(s)

Development of post-mastectomy pain syndrome

Secondary Outcome(s)

Rate of post-surgical pain
Rate of emotional distress
Rate of acute and chronic pain

Outline

This is a multicenter study.

Patients complete multiple questionnaires, including Hospital Anxiety and Depression Scale (HAD), Maudsley Personality Inventory (MPI), PCS, and QLQ-C30, to evaluate psychological variables (alexithymia, neurosis, repression of negative emotions, solicitude, dramatization, emotional distress) and quality of life.

Post-mastectomy chronic pain (PMCP) syndrome is measured immediately after surgery and at 24 hours, day 6, and 5 months post-surgery.

A subgroup of patients (20 with PMCP and 20 without PMCP) are followed at months 5 and 6 months post-surgery for medication use, pathological problems, morbid events, family history, and environmental factors.

Trial Contact Information

Trial Lead Organizations

Institut Bergonie

Florence Dixmerias, MD, Protocol chair
Ph: 33-556-333-264

Registry Information
Official Title Study of Psychological and Sociological Predisposing the Development of Chronic Pain After Surgery in Women With Resectable Breast Cancer
Trial Start Date 2005-09-26
Registered in ClinicalTrials.gov NCT00466830
Date Submitted to PDQ 2007-03-22
Information Last Verified 2007-05-22

Note: The purpose of most clinical trials listed in this database is to test new cancer treatments, or new methods of diagnosing, screening, or preventing cancer. Because all potentially harmful side effects are not known before a trial is conducted, dose and schedule modifications may be required for participants if they develop side effects from the treatment or test. The therapy or test described in this clinical trial is intended for use by clinical oncologists in carefully structured settings, and may not prove to be more effective than standard treatment. A responsible investigator associated with this clinical trial should be consulted before using this protocol.

Back to TopBack to Top

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov